SLC1A5 and Miyoshi myopathy: L-γ-glutamyl-p-nitroanilide (GPNA), the most used ASCT2 inhibitor, significantly reduces Gln uptake and hampers proliferation of MM cells, demonstrating their dependence on extracellular Gln (6).